The global medical tuberculin syringes market is projected to reach $230 million by 2033, growing at a CAGR of 5%. Driven by rising TB prevalence and vaccination rates, this market sees key players like BD and Cardinal Health innovating in safety and design. Learn more about market trends, growth drivers, and key players in this detailed analysis.

Our Clients

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.